NeuroCONCISE Technology develops wearable EEG-based brain-computer interface (BCI) technology for measuring and analysing brain activity in clinical and research contexts. The company positions its work around objective assessment and communication support for patients with severe neurological impairment.

The platform combines wearable EEG acquisition with AI-driven signal processing to translate brain activity into interpretable outputs and control signals. NeuroCONCISE describes a software suite built around brainwave measurement, analysis, and BCI decoding, with deployment designed to fit into existing neurotechnology workflows.

Stated use cases include supporting assessment of traumatic brain injury and disorders of consciousness, and enabling basic channels of communication where movement is limited. The company also frames applications in rehabilitation, including stroke survivor pathways, and broader assistive interaction with computers and devices.